Flerie Invest AB made an offer to acquire remaining 67.99% stake in Lipum AB (publ) (OM:LIPUM) for SEK 41.8 million on March 6, 2024. The Offer is conditional upon all permits, approvals, decisions and other measures required for the Offer from authorities or similar, including from the Swedish Inspectorate of Strategic Products, under the Swedish Act on review of foreign direct investments, having been obtained, in each case, on terms acceptable to Flerie. The acceptance period for the Offer commenced on March 7, 2024, and expires on April 4, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.4 SEK | +2.40% | -3.03% | -1.84% |
06/05 | Lipum Obtains SEK20 Million Loan from Flerie Invest | MT |
02/04 | Lipum Strengthens Its Protection of the Drug Candidate Sol-116 Through A Patent Application for Inflammation-Driven Cancer | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.84% | 12.36M | |
-2.21% | 89.22B | |
+1.32% | 40.49B | |
-15.73% | 32.79B | |
+64.13% | 26.23B | |
-21.28% | 14.52B | |
-8.50% | 13.09B | |
-44.07% | 11.6B | |
-13.06% | 11.5B | |
+4.94% | 8.82B |
- Stock Market
- Equities
- LIPUM Stock
- News Lipum AB
- Flerie Invest AB made an offer to acquire remaining 67.99% stake in Lipum AB (OM: LIPUM) for SEK 41.8 million.